IASLC Staging ArticleThe IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer
Under an Elsevier user license
open archive
Key Words
IASLC International Staging Committee
TNM classification of lung cancer
Lung cancer staging
Tumor size
Malignant pleural effusion
Complete resection
Cited by (0)
Eli Lilly and Company provided funding to support the International Association for the Study of Lung Cancer (IASLC) Staging Committee's work to establish a database and to suggest revisions to the sixth edition of the TNM classification for lung cancer (staging) through a restricted grant. Lilly had no input into the committee's analysis of the data or into their suggestions for revisions to the staging system. Dr. Jett has served on a Data Safety Monitoring Board for Phase III clinical trials for Pfizer and Astra Zeneca and on an advisory panel for Lilly, Inc. None of those drugs are discussed or mentioned in this manuscript.
- a
See Appendix 1.
Copyright © 2007 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.